SynBioBeta Speaker
Michael Hershkowitz
IFF
Dir., Sustainable Innovation
Michael Hershkowitz works at the intersection of industrial biotech, product development, and sustainability. Over the course of his career, he has worked across enzymes, bioproducts, and consumer applications, including roles at IFF, Novozymes, The Clorox Company, and Cobalt Technologies. He brings a practical perspective on how enzyme technologies can improve performance, reduce resource intensity, and open new possibilities in cleaning, food production, and biomaterials. He holds a degree in Chemical and Biomolecular Engineering from Georgia Tech and an MBA from NC State.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Michael
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
